Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (241-250 of 574) with videos related to

Pageof 58
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 21, 2022
Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancerJulien Mazieres, Laura Iadeluca, Alice T Shaw, et al.
Cancer|July 14, 2011
Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only studyRihong Zhai, Yang Zhao, Geoffrey Liu, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 16, 2017
Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputationSteven Habbous, Karen P Chu, Harold Lau, et al.
Future Oncology (London, England)|September 29, 2021
Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancerBenjamin J Solomon, Todd M Bauer, Filippo de Marinis, et al.
Cancer Management and Research|February 28, 2020
Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer CenterMin Joon Lee, Katrina Hueniken, Nathan Kuehne, et al.
The New England Journal of Medicine|November 18, 2020
First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i>-Positive Lung CancerAlice T Shaw, Todd M Bauer, Filippo de Marinis, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|March 19, 2026
Clinical Factors and Income Status are Associated with Depression and Anxiety in Head and Neck Cancer PatientsAshok R Jethwa, Catriona M Douglas, Katrina Hueniken, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2020
Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer ConsortiumYonathan Brhane, Ping Yang, David C Christiani, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|July 26, 2024
Clinical Predictors of Cisplatin Chemoradiation-Induced Ototoxicity in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Case-Control StudyJohn Jw Lee, Salahaldin Alamleh, Luna Jia Zhan, et al.
Cancer|June 15, 2013
Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patientsAidin Kashigar, Steven Habbous, Lawson Eng, et al.
Pageof 58

Showing results (241-250 of 574) with videos related to

Sort By:
Pageof 58
Lung Cancer (Amsterdam, Netherlands)|November 21, 2022
Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancerJulien Mazieres, Laura Iadeluca, Alice T Shaw, et al.
Cancer|July 14, 2011
Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only studyRihong Zhai, Yang Zhao, Geoffrey Liu, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 16, 2017
Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputationSteven Habbous, Karen P Chu, Harold Lau, et al.
Future Oncology (London, England)|September 29, 2021
Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancerBenjamin J Solomon, Todd M Bauer, Filippo de Marinis, et al.
Cancer Management and Research|February 28, 2020
Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer CenterMin Joon Lee, Katrina Hueniken, Nathan Kuehne, et al.
The New England Journal of Medicine|November 18, 2020
First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i>-Positive Lung CancerAlice T Shaw, Todd M Bauer, Filippo de Marinis, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|March 19, 2026
Clinical Factors and Income Status are Associated with Depression and Anxiety in Head and Neck Cancer PatientsAshok R Jethwa, Catriona M Douglas, Katrina Hueniken, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2020
Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer ConsortiumYonathan Brhane, Ping Yang, David C Christiani, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|July 26, 2024
Clinical Predictors of Cisplatin Chemoradiation-Induced Ototoxicity in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Case-Control StudyJohn Jw Lee, Salahaldin Alamleh, Luna Jia Zhan, et al.
Cancer|June 15, 2013
Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patientsAidin Kashigar, Steven Habbous, Lawson Eng, et al.
Pageof 58